|
US4849411A
(en)
*
|
1982-11-09 |
1989-07-18 |
Scripps Clinic And Research Foundation |
Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
|
|
US5476659A
(en)
*
|
1982-11-09 |
1995-12-19 |
The Scripps Research Institute |
Cancerous B cell treatment using substituted nucleoside derivatives
|
|
US4900675A
(en)
*
|
1983-11-01 |
1990-02-13 |
Scripps Clinic And Research Foundation |
Modulation of animal cellular responses with compositions containing isoxanthopterin-8-(1'-β-aldoglycosidyl) derivatives
|
|
US5166141A
(en)
*
|
1983-11-01 |
1992-11-24 |
Scripps Clinic And Research Foundation |
Immunostimulating 7-deaza-7-oxa- and 7-deaza-7-oxo-analogs of 8-substituted-guanine-9-(1'-beta-D-aldoglycosidyl) derivatives and methods of treating test animals
|
|
US5093318A
(en)
*
|
1983-11-01 |
1992-03-03 |
Scripps Clinic And Research Foundation |
Immunostimulating guanosine derivatives and their pharmaceutical compositions
|
|
FR2560212B1
(fr)
*
|
1984-02-24 |
1989-12-29 |
Unicet |
Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps
|
|
US5011828A
(en)
*
|
1985-11-15 |
1991-04-30 |
Michael Goodman |
Immunostimulating guanine derivatives, compositions and methods
|
|
ZA869297B
(en)
*
|
1985-12-13 |
1987-11-25 |
Scripps Clinic Res |
Modulation of animal cellular responses with compositions containing isoxanthopterin-8-(1'-beta-aldoglycosidyl)derivatives
|
|
US6060459A
(en)
*
|
1987-10-28 |
2000-05-09 |
Pro-Neuron, Inc. |
Enhancing blood cell count with oxypurine nucleosides
|
|
US4880784A
(en)
*
|
1987-12-21 |
1989-11-14 |
Brigham Young University |
Antiviral methods utilizing ribofuranosylthiazolo[4,5-d]pyrimdine derivatives
|
|
US4902985A
(en)
*
|
1988-02-25 |
1990-02-20 |
Raytheon Company |
Microwave reflectiion amplifiers having increased bandwidth
|
|
GB2216416B
(en)
*
|
1988-03-11 |
1992-06-24 |
Sandoz Ltd |
Nucleobase source for the stimulation of the immune system
|
|
ZA893063B
(en)
*
|
1988-04-27 |
1990-01-31 |
Immunomedics Inc |
Improved radiotherapy
|
|
WO1994011003A1
(en)
*
|
1992-11-13 |
1994-05-26 |
The Scripps Research Institute |
Cancerous b cell treatment using substituted nucleoside derivatives
|
|
US5786359A
(en)
*
|
1994-05-27 |
1998-07-28 |
The Scripps Research Institute |
N9 alkyl or aralkyl derivatives of 7, 8-disubstituted guanines
|
|
US5441942A
(en)
*
|
1994-05-27 |
1995-08-15 |
The Scripps Research Institute |
2'3'-dideoxy-2',3'-didehydro-7,8-disubstituted guanosines and their immunostimulative effect
|
|
US6338963B1
(en)
|
1994-07-25 |
2002-01-15 |
Neotherapeutics, Inc. |
Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
|
|
US20030100520A1
(en)
*
|
1997-01-21 |
2003-05-29 |
Philip Needleman |
Immunological process and constructs for increasing the hdl cholesterol concentration by dna vaccination
|
|
WO1999057120A1
(en)
|
1998-05-04 |
1999-11-11 |
Neotherapeutics, Inc. |
Novel serotonin-like 9-substituted hypoxanthine and methods of use
|
|
US6562801B1
(en)
*
|
1999-04-15 |
2003-05-13 |
Board Of Regents, The University Of Texas System |
PpGpp and pppGpp as immunomodulatory agents
|
|
US6288069B1
(en)
|
1999-11-16 |
2001-09-11 |
Neotherapeutics, Inc. |
Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
|
|
US6407237B1
(en)
|
2001-02-21 |
2002-06-18 |
Neotherapeutics, Inc. |
Crystal forms of 9-substituted hypoxanthine derivatives
|
|
US6849735B1
(en)
*
|
2000-06-23 |
2005-02-01 |
Merck Eprova Ag |
Methods of synthesis for 9-substituted hypoxanthine derivatives
|
|
EP1334104A2
(en)
|
2000-07-07 |
2003-08-13 |
Neotherapeutics, Inc. |
Methods for treatment of drug-induced peripheral neuropathy and related conditions
|
|
US20030138769A1
(en)
*
|
2000-08-16 |
2003-07-24 |
Birkett Ashley J. |
Immunogenic HBc chimer particles having enhanced stability
|
|
US6759427B2
(en)
*
|
2001-04-20 |
2004-07-06 |
Spectrum Pharmaceuticals, Inc. |
Synthesis and methods of use of tetrahydroindolone analogues and derivatives
|
|
EP1395262A4
(en)
*
|
2001-06-15 |
2006-04-12 |
Ribapharm Corp |
NUCLEOSIDE-VACCINE-ADJUVANTS
|
|
US20030055249A1
(en)
*
|
2001-07-17 |
2003-03-20 |
Fick David B. |
Synthesis and methods of use of pyrimidine analogues and derivatives
|
|
US7361352B2
(en)
*
|
2001-08-15 |
2008-04-22 |
Acambis, Inc. |
Influenza immunogen and vaccine
|
|
US20030175863A1
(en)
*
|
2001-08-15 |
2003-09-18 |
Birkett Ashley J. |
Influenza immunogen and vaccine
|
|
US7321033B2
(en)
*
|
2001-11-27 |
2008-01-22 |
Anadys Pharmaceuticals, Inc. |
3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof
|
|
US7351413B2
(en)
*
|
2002-02-21 |
2008-04-01 |
Lorantis, Limited |
Stabilized HBc chimer particles as immunogens for chronic hepatitis
|
|
CA2537450C
(en)
|
2003-09-05 |
2012-04-17 |
Anadys Pharmaceuticals, Inc. |
Administration of tlr7 ligands and prodrugs thereof for treatment of infection by hepatitis c virus
|
|
PT2561872E
(pt)
|
2004-12-17 |
2014-12-18 |
Anadys Pharmaceuticals Inc |
Compostos 3h-oxazolo[4,5-d]pirimidin-2-ona 3,5-di- -substituídos e 3,5,7-tri-substituídos e seus pró-fármacos
|
|
US7781581B2
(en)
|
2005-11-21 |
2010-08-24 |
Anadys Pharmaceuticals, Inc. |
Process for the preparation of 5-amino-3H-thiazolo[4,5-d]pyrimidin-2-one
|
|
BRPI0713680A2
(pt)
*
|
2006-06-22 |
2012-10-23 |
Anadys Pharmaceuticals Inc |
composto, composição farmacêutica e métodos de modulação das atividades imuno da citocina, de tratamento de infecção de vìrus da hepatite c em paciente e de tratamento de desordem de proliferação relacionada em mamìfero carecido do mesmo
|
|
BRPI0714831A2
(pt)
|
2006-07-18 |
2013-04-02 |
Anadys Pharmaceuticals Inc |
composto, composiÇço farmacÊutica e mÉtodos de modulaÇço de atividades imuno da citoquina em paciente, de tratamento de infecÇço de vÍrus c da hepatite em paciente e de desordem relacionada com proliferaÇço em mamÍfero necessitado do mesmo
|
|
CA2695399C
(en)
|
2007-08-02 |
2017-10-17 |
Biondvax Pharmaceuticals Ltd. |
Multimeric multiepitope influenza vaccines
|
|
AU2008331800A1
(en)
|
2007-12-03 |
2009-06-11 |
President And Fellows Of Harvard College |
Chlamydia antigens
|
|
JP2012510289A
(ja)
|
2008-12-03 |
2012-05-10 |
プロティア ワクチン テクノロジーズ リミテッド |
グルタミルｔＲＮＡ合成酵素（ＧｔＳ）フラグメント
|
|
TW201639852A
(zh)
|
2008-12-09 |
2016-11-16 |
吉李德科學股份有限公司 |
用於製備可用作類鐸受體調節劑之化合物的中間體化合物
|
|
WO2011067758A2
(en)
|
2009-12-02 |
2011-06-09 |
Protea Vaccine Technologies Ltd. |
Immunogenic fragments and multimers from streptococcus pneumoniae proteins
|
|
AU2011360572B2
(en)
|
2011-02-22 |
2017-03-02 |
Biondvax Pharmaceuticals Ltd. |
Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
|
|
WO2013150518A1
(en)
|
2012-04-01 |
2013-10-10 |
Rappaport Family Institute For Research In The Medical Sciences |
Extracellular matrix metalloproteinase inducer (emmprin) peptides and binding antibodies
|
|
CA2944768C
(en)
|
2014-04-03 |
2022-08-30 |
Biondvax Pharmaceuticals Ltd. |
Compositions of multimeric-multiepitope influenza polypeptides and their production
|
|
NZ728072A
(en)
|
2014-07-11 |
2018-06-29 |
Gilead Sciences Inc |
Modulators of toll-like receptors for the treatment of hiv
|
|
CA2960436C
(en)
|
2014-09-16 |
2021-01-05 |
Gilead Sciences, Inc. |
Solid forms of a toll-like receptor modulator
|